New: Our latest case study on qFibrosis' role in the successful development of Rezdiffra

Categories: Posters and abstracts

AI Digital pathology unmasked the No Change in conventional pathological assessment of MASLD patients with one year lifestyle intervention in a prospective cohort study

Poster ID: WED-319, EASL Congress 2024 Authors: Nikolai V Naoumov1, Yayun Ren, Elaine Chng2, Kutbuddin Akbary2, Dean Tai2, Jonathan Fallowfield3, Timothy Kendall3, David E Kleiner4, Arun J Sanyal5 1. Royal College of Physicians, London, United Kingdom 2. HistoIndex Pte Ltd, Singapore, Singapore 3. Institute for Regeneration and Repair, University of Edinburgh, Edinburgh, United Kingdom 4. …

AI Digital pathology unmasked the No Change in conventional pathological assessment of MASLD patients with one year lifestyle intervention in a prospective cohort study Read More »

Assessment of fibrosis changes rates in placebo arm of MASH drug trials based on pathologist readouts and qFibrosis continuous values

Poster ID: WED-213, EASL Congress 2024 Authors: Kutbuddin Akbary1, Dean Tai1, Galvin Gan1, Julie Dubourg2, Stephen A. Harrison3 1. HistoIndex Pte Ltd, Singapore, Singapore 2. Summit Clinical Research, San Antonio, TX, United States 3. Pinnacle Clinical Research, Radcliffe Department of Medicine, University of Oxford, Oxford, UK, San Antonio, TX, United States Background and Aims: Metabolic …

Assessment of fibrosis changes rates in placebo arm of MASH drug trials based on pathologist readouts and qFibrosis continuous values Read More »